|
Analgesia & Anti-inflammatory
Drug Development Guidance
Guidances Currently Available
Draft Guidances
- Clinical Development Programs for Drugs, Devices, and Biological
Products Intended for the Treatment of Osteoarthritis [HTML],
[PDF] or [WORD]
(Issued 7/07/1999, Posted 7/14/1999)
- Pharmacogenomic Data Submissions [Word] or [PDF]
(Issued 11/2003)
Arthritis
Drugs Advisory Committee Meeting Information
Back to Top
Analgesia & Anti-inflammatory
FDA/Center for Drug Evaluation and Research
Last Updated: August 1, 2005
Originator: OTCOM/DLIS
HTML by SJW |